Skip to main content
Premium Trial:

Request an Annual Quote

OncoCell: Marc Stapley

Molecular diagnostic firm OncoCell MDx has appointed Marc Stapley to its board of directors. Stapley currently serves as president and CEO of Helix and is a member of the Glaukos board of directors. Prior to Helix, Stapley served as executive VP at Illumina. At Illumina, he also served as the chief administrative officer and CFO. Before Illumina, he held executive finance positions at Pfizer and other large multinational companies. 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.